BRM:FRA
Bristol-Myers Squibb Co
52,97 €
0,00%
(0,00) 1d
19 d’oct., 15:38:05 GMT+2 · EUR
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a BRM...
Capitalització borsària
120,17 kM
Volum mitjà
221,00
Volum
0,00
Alt 52 setmanes
60,64 €
Baix 52 setmanes
36,65 €
Nombre d'empleats
32 k
Capitalització borsària
120,17 kM
Volum mitjà
221,00
Volum
0,00
Alt 52 setmanes
60,64 €
Baix 52 setmanes
36,65 €
Nombre d'empleats
32 k
Notícies
De fonts web i partners de notícies
TIKR.com
·
fa 8 hores
Better Dividend Stock: Merck vs. Bristol Myers Squibb
Yahoo Finance
·
fa 9 hores
Bristol Myers Squibb (BMY) Heads To ESMO 2026 With New Oncology Data
MarketWatch
·
fa 10 hores
Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors
Stock Traders Daily
·
fa 13 hores
Discipline and Rules-Based Execution in BMY Response
Perfil
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Sobre Bristol-Myers Squibb Co
Conseller delegatChris Boerner
Empleats32,5 k
Fundació1887
Seu principalNova York, Nova York, Estats Units d'Amèrica
Sector-
Lloc webbms.com